Bullboard Post History

by Biofinanace

Order by:

T.PAY	RE:Analyst Coverage? Stifel commentated in advance of May13th quaterly results - "Pay... April 29, 2021
T.PAY	Ray Jay & Stifel Reports on PayFare Please follow the link below for both reports - Ray Jay : https:/... April 23, 2021
C.AGN	RE:Data AGN becomes first Canadian company to share positive outcome from a covid... December 15, 2020
C.AGN	My (nail-biting) 2 cents In the morning when I woke up and saw INCY (JAK1/2 inhibitor) failed in Ph3... December 14, 2020
C.AGN	RE:My hopes Couldnt agree more ! December 13, 2020
C.AGN	AGN is on Paradigm Capital's Healthcare watchlist The list was created by Corey Hammill (Sr. Analyst) & Scott McAuley... December 13, 2020
C.AGN	RE:RE:RE:RE:Thank you IPF cough is VERY different than cough with underlying disease (acute/chronic... December 12, 2020
C.AGN	RE:RE:Thank you I will be more than happy to see such multipliers. Just to correct... December 11, 2020
C.AGN	RE:Dumb but honest question on ifenprodil AGN has filed method of use & composition of matter patents for certain... December 11, 2020
C.AGN	RE:Why Algernon could have the leading therapeutic COVID19 drug Very pleased to see AGN's coverage on BNN Thanks for sharing December 11, 2020
C.AGN	AGN vs Regeneron & Abcelera ? From competitive perspective - Below are the therapeutics (not vaccines) in... December 11, 2020
C.AGN	More eyes on AGN NP 120: Sanofi/GSK COVID Ph1/2 failure Today Sanofy/GSK (using protein fragment to prone the immune system against... December 11, 2020
C.AGN	AGN COVID Interim Outcome: What to expect? Perhaps a 2 point scale difference i.e 5 to 3 or 6 to 4 on 0-7 scale (75... December 10, 2020
C.AGN	AGN has BEST KOLs from Fibrosis/Cough Universe While we await for COVID NP120 interim data for 3rd week of Dec. I just want... December 9, 2020
C.AGN	Interim 75 patients Data might be good (Dec 14th Week) Based on the evidence generated by 2 independent groups speaks in favor of... December 6, 2020
C.AGN	For Cough In Vivo Model - NP 120 > Gefapixant, may be Bit of a history on BLU compound - I was not surprised to see when BLU 5937... December 6, 2020
C.AGN	Mackie Full Report - AGN (Aug 2020) Good Friday Read - Link will be deleted within 14 days https... December 4, 2020
C.AGN	RE:Reupload: Investment Thesis for AGN Apologies for the SPAM ! This is the hyperlink - https://ibb.co... December 4, 2020
C.AGN	Reupload: Investment Thesis for AGN Its difficult to copy and paste the image. I have created this link... December 4, 2020
C.AGN	RE:Investment thesis for AGN December 4, 2020

Become a member today, It's free!

Bullboard Post History

by Biofinanace

RE:Analyst Coverage?

Ray Jay & Stifel Reports on PayFare

RE:Data

My (nail-biting) 2 cents

RE:My hopes

AGN is on Paradigm Capital's Healthcare watchlist

RE:RE:RE:RE:Thank you

RE:RE:Thank you

RE:Dumb but honest question on ifenprodil

RE:Why Algernon could have the leading therapeutic COVID19 drug

AGN vs Regeneron & Abcelera ?

More eyes on AGN NP 120: Sanofi/GSK COVID Ph1/2 failure

AGN COVID Interim Outcome: What to expect?

AGN has BEST KOLs from Fibrosis/Cough Universe

Interim 75 patients Data might be good (Dec 14th Week)

For Cough In Vivo Model - NP 120 > Gefapixant, may be

Mackie Full Report - AGN (Aug 2020)

RE:Reupload: Investment Thesis for AGN

Reupload: Investment Thesis for AGN

RE:Investment thesis for AGN

Featured Company

Forge Resources Corp. C.FRG

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by Biofinanace

Featured Company